Recombinant Human NSE Protein, >95% (SDS-PAGE), high purity

Item Number

rp169606

• Product Name: Recombinant Human NSE Protein, >95% (SDS-PAGE), high purity
• Synonyms: 2 phospho D glycerate hydrolyase | 2-phospho-D-glycerate hydro-lyase | Eno 2 | ENO2 | ENOG | ENOG_HUMAN | Enolase 2 | Enolase 2 (gamma, neuronal) | Enolase 2 gamma neuronal | Enolase2 | Gamma enolase | Epididymis secretory protein Li 279 | Gamma-enolase |
• Grade: ActiBioPure™, Azide Free, Bioactive, Carrier Free
• Specifications & Purity: ActiBioPure™, Bioactive, Carrier Free, Azide Free, ≥95%(SDS-PAGE)
• Purity: >95% (SDS-PAGE)
• Bioactivity: Measured by its binding ability in a functional ELISA. Immobilized human NSE (rp169606) at 1.0 μg/mL can bind NSE Mouse mAb (Ab118776) with the ED50 of 4.75 ng/mL.
• Endotoxin Concentration: ＜1.0 EU/μg
• Expression System: E. coli
• Amino Acids: 1-434 aa
• Sequence: MHHHHHHSIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAAS
• Protein Tag: N-His
• Predicted molecular weight: 48.1 kDa
• SDS-PAGE: 46.6 kDa, under reducing conditions; 46.6 kDa, under non-reducing conditions

Product Description

Purity:>95%, by SDS-PAGE visualized with Coomassie® Blue Staining.
Description：
Neuron specific enolase (NSE), also known as ENO2 or gamma-enolase, is a dimeric, Mg2+-dependent enzyme that catalyzes the dehydration of 2-phospho-D glycate (PGA) to phosphoenolpyruvate (PEP) in the glycolytic pathway and catalyzes the reverse reaction in gluconeogenesis. There are three major isozymes of enolase expressed in selective vertebrate tissues from separate genes: alpha (ENO1), beta (ENO3), and gamma (ENO2). NSE is a highly expressed, specific neuron isozyme making it a useful marker for tumors derived from neuronal cells. Neuron-specific enolase is implicated as a diagnostic and prognostic marker in numerous diseases including early small cell lung cancer, prostate cancer, multiple myeloma, traumatic brain injury, acute spinal cord injury, acute ischemic stroke, and post-concussion symptoms. NSE expression and activity are increased in neuronal and glial activation and injury, risk factors implicated in neurodegenerative disease. Elevation of NSE promotes glycolysis, proliferation, activation and migration through its C-terminus to activate PI3K and MAPK signal transduction pathways while inhibition of enolase has been shown to attenuate inflammatory events. NSE can be regulated through cleavage of the C-termini by cathepsin X or inhibited directly by antibiotic SF2312. Inhibition has been proposed as a therapeutic strategy in cancer.